Sepsis biomarkers and uses thereof
A biomarker, sepsis technology, applied in sepsis biomarkers and their application fields, can solve problems such as failure to identify pathogenic organisms, attempts to complicate, and aggravate disease
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0083] The present invention uses a polygenic marker approach as a diagnostic biomarker derived from a gene expression profile in leukocytes isolated from a subject's blood sample, which provides a significantly more accurate and faster diagnostic method than existing methods. Advantageously, gene expression profiling overcomes, or at least reduces, the problem of delayed diagnosis of sepsis since up- or down-regulation of genes occurs prior to synthesis of functional gene products such as pro-inflammatory proteins. Advantageously, the present invention can reliably and accurately classify individuals with sepsis, or provide prognostic clues to the progression of the syndrome, allowing more effective therapeutic intervention.
[0084] Conduct a cohort study. The objectives of the cohort study on patients with sepsis in the emergency department include: (i) obtaining and confirming gene expression panels differentially expressed in leukocytes of patients with and without sepsis...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com